Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: Structure-activity relationships

Toxicology and Applied Pharmacology

Volumn 145, Issue 1, 1997, Pages 111-123

  Connor, K ^a   Ramamoorthy, K ^a   Moore, M ^a   Mustain, M ^a   Chen, I ^a   Safe, S ^a   Zacharewski, T ^b   Gillesby, B ^b   Joyeux, A ^c   Balaguer, P ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; PEROXIDASE; POLYCHLORINATED BIPHENYL; PROGESTERONE RECEPTOR; TETRACHLOROBIPHENYL;

ARTICLE; BREAST CANCER; DRUG ACTIVITY; ESTROGEN ACTIVITY; FEMALE; HELA CELL; MOUSE; NONHUMAN; RAT; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; UTERUS;

FELIS CATUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 0031193490     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8169     Document Type: Article

References (50)

1. Andersson O., Nordlund-Möller L., Barnes H. J., Lund J. Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. J. Biol. Chem. 269:1994;19081-19087.
2. Balaguer P., Joyeux A., Denison M. S., Vincent R., Gillesby B. E., Zacharewski T. Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures usingin vitro. Can. J. Physiol. Pharmacol. 74:1996;216-222.
3. Ballschmiter K., Rappe C., Buser H. R. Chemical properties, analytical and environmental levels of PCBs, PCTs, PCNs and PCBs. Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products. 1989;Elsevier-North Holland, Amsterdam. p. 47-69.
4. Bandiera S., Safe S., Okey A. B. Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene-, or mixed-type inducers to cytosolic Ah receptor. Chem.-Biol. Interact. 39:1982;259-277.
5. Berberian I., Chen L.-C., Robinson F. R., Glauert H. P., Chow C. K., Robertson L. W. Effect of dietary retinyl palmitate on the promotion of altered hepatic foci by 3,3′,4,4′-tetrachlorobiphenyl and 2,2′,4,4′,5,5′-hexachlorobiphenyl in rats initiated with diethylnitrosamine. Carcinogenesis. 16:1995;393-398.
6. Bergman Å., Klasson-Wehler E., Kuroki H. Selective retention of hydroxylated PCB metabolites in blood. Environ. Health Perspect. 102:1994;464-469.
7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Brandt I., Lund J., Bergman Å., Klasson-Wehler E., Poellinger L., Gustafsson J. Target cells for the polychlorinated biphenyl metabolite 4,4′-bis(methylsulfonyl)-2,2′,5,5′-tetrachlorobiphenyl in lung and kidney. Drug Metab. Dispos. 13:1985;490-496.
9. Brasier A. R., Tate J. E., Habener J. F. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques. 7:1989;1116-1122.
10. Brouwer A., Blaner W. S., Kukler A., Van den Berg K. J. Study on the mechanism of interference of 3,4,3′,4′-tetrachlorobiphenyl with the plasma retinol-binding proteins in rodents. Chem.-Biol. Interact. 68:1988;203-217.
11. Brouwer A., Klasson-Wehler E., Bokdam M., Morse D. C., Traag W. A. Competitive inhibition of thyroxin binding to transthyretin by mono-hydroxy metabolites of 3,4,3′,4′-tetrachlorobiphenyl. Chemosphere. 20:1990;1257-1262.
12. Brouwer A., Van den Berg K. J. Binding of a metabolite of 3,4,3′,4′-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicol. Appl. Pharmacol. 85:1986;301-312.
13. Brown M., Sharp P. A. Human estrogen receptor multiple protein-DNA complexes. J. Biol. Chem. 265:1990;11238-11243.
14. Connor K., Safe S., Jefcoate C. R., Larsen M. Structure-dependent induction of CYB2B by polychlorinated biphenyl congeners in female Sprague-Dawley rats. Biochem. Pharmacol. 50:1995;1913-1920.
15. Curtis S. W., Korach K. S. Uterine estrogen receptor interaction with estrogen responsive DNA sequencesin vitro: Mol. Endocrinol. 4:1990;276-286.
16. Gagne D., Balaguer P., Demirpence E., Trousse F., Nicolas J. C., Pons M. Stable transfectant cells to study steroid receptor biological activity. J. Biolum. Chem. 9:1994;201-209.
17. Hemming H., Flodström S., Wärngård L., Bergman Å., Kronevi T., Nordgren I., Ahlborg U. G. Relative tumour promoting activity of three polychlorinated biphenyls in rat liver. Eur. J. Pharmacol. 248:1993;163-174.
18. Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L. Nuclear receptor coactivators corepressors. Mol. Endocrinol. 10:1996;1167-1177.
19. Hyder S. M., Shipley G. L., Stancel G. M. Estrogen action in target cells: Selective requirements for activation of different hormone response elements. Mol. Cell. Endocrinol. 112:1995;35-43.
20. Jausons-Loffreda N., Gelmini N., Pazzagli N., Joyeux A., Balaguer P., Pons M., Nicolas J. C. Chimeric receptor genes as a tool for measuring biological activities of steroid hormones. J. Biolum. Chem. 9:1994;31-38.
21. Kannan N., Tanabe S., Ono M., Tatsukawa R. Critical evaluation of polychlorinated biphenyl toxicity in terrestrial and marine mammals: Increasing impact of non-orthoortho. Arch. Environ. Contam. Toxicol. 18:1989;850-857.
22. Katzenellenbogen J. A. The structural pervasiveness of estrogenic activity. Environ. Health Persp. 103:1995;99-101.
23. Katzenellenbogen J. A., O'Malley B. W., Katzenellenbogen B. S. Tripartite steroid hormone receptor pharmacology - Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:1996;119-131.
24. Klein-Hitpass L., Schorpp M., Wagner U., Ryffel G. U. An estrogen-responsive element derived from the 5′-flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 46:1986;1053-1061.
25. Kodavanti P. R. S., Shin D., Tilson H. A., Harry G. J. Comparative effects of two polychlorinated biphenyl congeners on calcium homeostasis in rat cerebellar granule cells. Toxicol. Appl. Pharmacol. 123:1993;97-106.
26. 3. Toxicol. Appl. Pharmacol. 130:1995;140-148.
27. Korach K. S., Sarver P., Chae K., McLachlan J. A., McKinney J. D. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: Conformationally restricted structural probes. Mol. Pharmacol. 33:1988;120-126.
28. Lans M. C., Klasson-Wehler E., Willemsen M., Meussen E., Safe S., Brouwer A. Structure-dependent competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p. Chem.-Biol. Interact. 88:1993;7-21.
29. Lyttle C. R., DeSombre E. R. Uterine peroxidase as a marker for estrogen action. Proc. Natl. Acad. Sci. USA. 74:1977;3162-3166.
30. Maier W. E., Kodavanti P. R., Harry G. J., Tilson H. A. Sensitivity of adenosine triphosphatases in different brain regions to polychlorinated biphenyl congeners. J. Appl. Toxicol. 14:1994;225-229.
31. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The nuclear receptor superfamily: The second decade. Cell. 83:1995;835-839.
32. McDonnell D. P., Clemm D. L., Hermann T., Goldman M. E., Pike J. W. Analysis of estrogen receptor functionin vitro. Mol. Endocrinol. 9:1995;659-669.
33. McFarland V. A., Clarke J. U. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: Considerations for a congener-specific analysis. Environ. Health Perspect. 81:1989;225-239.
34. Moore M., Mustain M., Daniel K., Safe S., Zacharewski T., Gillesby B., Joyeux A., Balaguer P. Antiestrogenicity activity of hydroxylated PCBs identified in human serum. Toxicol. Appl. Pharmacol. 142:1997;160-168.
35. Parkinson A., Safe S., Robertson L., Thomas P. E., Ryan D. E., Levin W. Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated and polybrominated biphenyls: A study of structure activity relationships. J. Biol. Chem. 258:1983;5967-5976.
36. Pham T. A., Elliston J. F., Nawaz Z., McDonnell D. P., Tsai M. J., O'Malley B. W. Anti-estrogen can establish non-productive complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. USA. 88:1991;3125-3129.
37. Pons M., Gagne D., Nicolas J. C., Methali M. A new cellular model of response to estrogens: A bioluminescent test to characterize (anti)estrogen molecules. Biotechniques. 9:1990;450-459.
38. Safe S. Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): Biochemistry, toxicology and mechanism of action. C.R.C. Crit. Rev. Toxicol. 12:1984;319-395.
39. Safe S. Polyhalogenated aromatics: uptake, disposition and metabolism. Kimbrough R. D., Jensen A. A. Halogenated Biphenyls, Naphthalene, Dibenzodioxins and Related Compounds. 1989;51-69 Elsevier-North Holland, Amsterdam.
40. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p. C.R.C. Crit. Rev. Toxicol. 21:1990;51-88.
41. Safe S. Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. C.R.C. Crit. Rev. Toxicol. 24:1994;87-149.
42. Safe S., Washburn K., Zacharewski T., Phillips T. D. Synthesis and characterization of hydroxylated polychlorinated biphenyls (PCBs) identified in human serum. Chemosphere. 31:1995;3017-3023.
43. Seegal R. F., Bush B., Shain W. Lightly chlorinatedortho. Toxicol. Appl. Pharmacol. 106:1990;136-144.
44. Seegal R. F., Bush B., Brosch K. O. Comparison of effects of Aroclors 1016 and 1260 on non-human primate catecholamine function. Toxicology. 66:1991;145-163.
45. Sipes I. G., Schnellmann R. G. Biotransformation of PCBs: Metabolic pathways and mechanisms. Safe S., Hutzinger O. Polychlorinated Biphenyls (PCBs): Mammalian and Environmental Toxicology. 1987;97-110 Springer-Verlag, Heidelberg.
46. Soto A. M., Sonnenschein C., Chung K. L., Fernandez M. F., Olea N., Serrano F. O. The E-screen assay as a tool to identify estrogens - An update on estrogenic environmental pollutants. Environ. Health Persp. 103:1995;113-122.
47. Tzukerman M. T., Esty A., Santiso-Mere D., Danielian P., Parker M. G., Stein R. G., Pike J. W., McDonnell D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
48. White R., Lees J. A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1:1987;735-744.
49. Whitlock J. P. Jr. Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6:1993;754-763.
50. Zacharewski T., Bondy K., McDonell P., Wu Z. F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p. Cancer Res. 54:1994;2707-2713.